A 33-year-old woman presents to her primary care physician for non-bloody nipple discharge. She states that it has been going on for the past month and that it sometimes soils her shirt. The patient drinks 2 to 3 alcoholic beverages per day and smokes 1 pack of cigarettes per day. She is currently seeking mental health treatment with an outpatient psychiatrist after a recent hospitalization for auditory hallucinations. Her psychiatrist prescribed her a medication that she can not recall. Otherwise, she complains of headaches that occur frequently. Her temperature is 98.6°F (37.0°C), blood pressure is 137/68 mmHg, pulse is 70/min, respirations are 13/min, and oxygen saturation is 98% on room air. Physical exam is notable for bilateral galactorrhea that can be expressed with palpation. Which of the following is the best next step in management?

Discontinuation of current psychiatric medications

A 37-year-old woman presents to her primary care physician for bilateral nipple discharge. The patient states that she has observed a milky discharge coming from her nipples for the past month. On review of systems, the patient states that she has felt fatigued lately and has experienced decreased libido. She also endorses headaches that typically resolve by the middle of the day and a 5 pound weight gain this past month. The patient has a past medical history of obesity, schizophrenia, and constipation. Her temperature is 99.5°F (37.5°C), blood pressure is 145/95 mmHg, pulse is 60/min, respirations are 15/min, and oxygen saturation is 98% on room air. On physical exam, you note an obese, fatigued-appearing woman. Dermatologic exam reveals fine, thin hair over her body. Cardiopulmonary exam is within normal limits. Neurological exam reveals cranial nerves II-XII as grossly intact. The patient exhibits 1+ sluggish reflexes. Which of the following is the most likely diagnosis?

Autoimmune destruction of the thyroid gland

Dopamine blockade in the tuberoinfundibular pathway

Viral infection of the thyroid gland

A 29-year-old nulligravid woman comes to the physician because of a 10-day history of small quantities of intermittent, blood-tinged discharge from her left nipple. There is no personal or family history of serious illness. She has smoked 1 pack of cigarettes daily for 5 years. Her last menstrual period was 12 days ago. She is sexually active and uses condoms inconsistently. Physical examination shows scant serosanguinous fluid expressible from the left nipple. There is no palpable breast mass or axillary lymphadenopathy. Examination shows no other abnormalities. Which of the following is the most appropriate next step in management?

Image-guided core biopsy of the affected duct

A 47-year-old woman comes to the physician for a mass in her left breast she noticed 2 days ago during breast self-examination. She has hypothyroidism treated with levothyroxine. There is no family history of breast cancer. Examination shows large, moderately ptotic breasts. The mass in her left breast is small (approximately 1 cm x 0.5 cm), firm, mobile, and painless. It is located 4 cm from her nipple-areolar complex at the 7 o'clock position. There are no changes in the skin or nipple, and there is no palpable axillary adenopathy. No masses are palpable in her right breast. A urine pregnancy test is negative. Mammogram showed a soft tissue mass with poorly defined margins. Core needle biopsy confirms a low-grade infiltrating ductal carcinoma. The pathological specimen is positive for estrogen receptors and negative for progesterone and human epidermal growth factor receptor 2 (HER2) receptors. Staging shows no distant metastatic disease. Which of the following is the most appropriate next step in management?

Lumpectomy with sentinel lymph node biopsy, followed by radiation and hormone therapy

Lumpectomy with sentinel lymph node biopsy followed by hormone therapy

Nipple-sparing mastectomy with axillary lymph node dissection followed by hormone therapy

Nipple-sparing mastectomy with axillary lymph node dissection, followed by radiation and hormone therapy

Radical mastectomy followed by hormone therapy

A 50-year-old obese woman presents for a follow-up appointment regarding microcalcifications found in her left breast on a recent screening mammogram. The patient denies any recent associated symptoms. The past medical history is significant for polycystic ovarian syndrome (PCOS), for which she takes metformin. Her menarche occurred at age 11, and the patient still has regular menstrual cycles. The family history is significant for breast cancer in her mother at the age of 72. The review of systems is notable for a 6.8 kg (15 lb) weight loss in the past 2 months. The vital signs include: temperature 37.0°C (98.6°F), blood pressure 130/70 mm Hg, pulse 82/min, respiratory rate 17/min, and oxygen saturation 98% on room air. On physical examination, the patient is alert and cooperative. The breast examination reveals no palpable masses, lymphadenopathy, or evidence of skin retraction. A biopsy of the left breast is performed, and histologic examination demonstrates evidence of non-invasive malignancy. Which of the following is the most appropriate definitive treatment for this patient?

Observation with bilateral mammograms every 6 months

A 58-year-old woman underwent mastectomy for multicentric DCIS. Final pathology shows high-grade DCIS with comedonecrosis, margins negative by 3 mm, no invasion identified in 40 tissue blocks examined. Sentinel lymph node biopsy shows isolated tumor cells (0.1 mm cluster) positive for cytokeratin. The medical oncologist requests input on systemic therapy. Evaluate the significance of the nodal finding and recommendations.

Consider isolated tumor cells clinically insignificant, node-negative staging, endocrine therapy only if ER-positive

Upstage to invasive cancer, recommend chemotherapy and endocrine therapy

Perform completion axillary dissection to assess additional nodal involvement

Recommend axillary radiation and systemic chemotherapy

Repeat pathology review to identify occult invasion

A 36-year-old woman with BRCA2 mutation and strong family history of breast and ovarian cancer desires risk-reducing surgery. She has 2 young children and plans to have one more child in 2 years. She asks about timing of risk-reducing mastectomy and oophorectomy. Her mother died of ovarian cancer at age 45, and sister diagnosed with breast cancer at age 38. Evaluate the optimal counseling regarding surgical timing.

Risk-reducing oophorectomy now, mastectomy after completion of childbearing

Perform both risk-reducing mastectomy and oophorectomy immediately

Defer both surgeries until after childbearing is complete

Risk-reducing mastectomy now, oophorectomy after completion of childbearing

Annual screening only until age 40, then reconsider surgery

A 42-year-old premenopausal woman with newly diagnosed 2.5 cm triple-negative breast cancer and 3 positive axillary lymph nodes completed neoadjuvant chemotherapy. Post-treatment MRI shows residual 1 cm mass in breast and 1 abnormal lymph node. She desires breast conservation. The tumor board must evaluate the surgical plan considering residual disease burden and emerging data on post-neoadjuvant therapy.

Lumpectomy, axillary dissection, and consider pembrolizumab based on residual disease

Mastectomy with reconstruction, no additional systemic therapy

Additional neoadjuvant chemotherapy until complete response

Lumpectomy, sentinel node biopsy only, regional nodal radiation

Lumpectomy, completion axillary dissection, standard adjuvant radiation

A 70-year-old woman with multiple comorbidities (COPD, CHF, DM) presents with a 3 cm palpable breast mass. Core biopsy shows invasive ductal carcinoma, ER-positive (95%), PR-positive (90%), HER2-negative, grade 1, Ki-67 5%. Staging shows no metastases. Her surgical risk is assessed as high (ASA class 4). Analyze the optimal treatment approach.

Primary endocrine therapy with aromatase inhibitor alone

Neoadjuvant chemotherapy followed by surgery

Lumpectomy under local anesthesia with sedation

Modified radical mastectomy under general anesthesia

Observation with serial imaging

Nipple discharge evaluation — USMLE Lesson

💧 Leaky Faucets Explained

Pathologic discharge is typically unilateral, spontaneous, and from a single duct.

Cause	Discharge Type	Key Features / Histo
Intraductal Papilloma	Bloody/Serosanguineous	Benign papillary growth in a large duct. Fibrovascular core lined by epithelial & myoepithelial cells.
DCIS/Invasive Ca	Bloody/Serosanguineous	Malignant cells within duct, no myoepithelial layer. May have associated mass.
Mammary Duct Ectasia	Green/Brown, sticky	Periductal inflammation, plasma cells, duct dilation with lipid-laden macrophages.
Physiologic/Galactorrhea	Milky, bilateral	↑ Prolactin. Requires bilateral, multi-duct expression. Check TSH, pregnancy test.

🕵️ The Discharge Detective

Initial Assessment: Differentiate physiologic vs. pathologic.
- Physiologic: Bilateral, multiductal, non-bloody (milky/yellow/green).
  - Workup: Pregnancy test, TSH, prolactin.
  - Causes: Galactorrhea (prolactinoma, hypothyroidism, drugs), pregnancy.
- Pathologic: Unilateral, uniductal, bloody, serosanguineous, or clear/watery.
  - Causes: Intraductal papilloma, duct ectasia, malignancy (DCIS/IDC).

⭐ The most common cause of unilateral, bloody nipple discharge is a benign intraductal papilloma, not malignancy.

Pathologic Discharge Workup Algorithm:

💧 Fixing the Flow

Physiologic: Bilateral, multi-ductal, milky/yellow/green. Often expressible, not spontaneous. Causes: pregnancy, lactation, hyperprolactinemia, hypothyroidism.
Pathologic: Unilateral, uni-ductal, spontaneous, bloody (papilloma, cancer), serosanguinous, or clear (cancer). Warrants full workup.

⭐ The most common cause of unilateral, bloody nipple discharge is a benign intraductal papilloma. However, malignancy must always be ruled out.

Galactogram: Intraductal papilloma filling defect

⚡ Biggest Takeaways

Pathologic discharge is typically unilateral, uniductal, and spontaneous (bloody/serous); physiologic is often bilateral and multiductal.

The most common cause of bloody nipple discharge is a benign intraductal papilloma.

Always rule out malignancy, especially Ductal Carcinoma In Situ (DCIS) or invasive cancer.

Initial workup for pathologic discharge includes mammography and ultrasound, particularly in women >30.

For milky, bilateral discharge (galactorrhea), check prolactin and TSH levels.

If imaging is negative but discharge remains suspicious, terminal duct excision is diagnostic.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

UNLOCK FREE ACCESS